Data / Drug companies / Richmond Pharmaceuticals, Inc.
Richmond Pharmaceuticals, Inc.: 27 products in the FDA NDC directory, labeler code 54738
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Richmond Pharmaceuticals, Inc. (labeler code 54738) lists 27 products in the FDA National Drug Code Directory, covering 15 finished drugs by generic name. By type: 26 over the counter drugs, 1 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 21, 2024.
The request: Watch Richmond Pharmaceuticals, Inc. (FDA labeler code 54738): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 54738
- Products in commercial distribution
- 27
- Packages
- 46
- Finished drugs by generic name
- 15
- Prescription products
- 1
- Over the counter products
- 26
- Flagged as original packager
- 27 of 27 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- February 15, 2000
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 24 | 88.9% |
| Other unapproved drugs | 2 | 7.4% |
| Generic drugs (ANDA) | 1 | 3.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 26 | 96.3% |
| Prescription drugs | 1 | 3.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Aspirin | 4 | 134 |
| Diphenhydramine hydrochloride | 4 | 127 |
| Acetaminophen | 4 | 214 |
| Ferrous sulfate | 2 | 2 |
| Magnesium oxide | 2 | 13 |
| Sodium bicarbonate | 2 | 51 |
| Sucralfate | 1 | 39 |
| Meclizine hcl 25mg chewable tablets | 1 | 3 |
| Calcium carbonate | 1 | 101 |
| Simethicone | 1 | 86 |
| Chlorpheniramine maleate | 1 | 31 |
| Guaifenesin 200 mg | 1 | 2 |
| Guaifenesin and dextromethorphan hbr | 1 | 26 |
| Bismuth subsalicylate | 1 | 80 |
| Guaifenesin 400 mg | 1 | 8 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 16 | 59.3% |
| Tablet, chewable | 6 | 22.2% |
| Capsule | 4 | 14.8% |
| Suspension | 1 | 3.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sucralfate | 54738-005 | Suspension | Generic drugs (ANDA) | November 21, 2024 |
| Mucus Relief Cough and Congestion DM | 54738-985 | Tablet | Over the counter monograph drugs | April 1, 2016 |
| Mucus Relief | 54738-981 | Tablet | Over the counter monograph drugs | March 1, 2016 |
| Mucus Relief | 54738-980 | Tablet | Over the counter monograph drugs | March 1, 2016 |
| Magnesium Oxide | 54738-974 | Tablet | Over the counter monograph drugs | February 1, 2016 |
| Magnesium Oxide | 54738-973 | Tablet | Over the counter monograph drugs | February 1, 2016 |
| Ferrous sulfate | 54738-963 | Tablet | Other unapproved drugs | June 1, 2015 |
| Aspirin | 54738-541 | Tablet | Over the counter monograph drugs | June 1, 2015 |
| Pepto Relief | 54738-102 | Tablet, chewable | Over the counter monograph drugs | June 1, 2015 |
| Sodium Bicarbonate Antacid | 54738-035 | Tablet | Over the counter monograph drugs | June 1, 2015 |
| Acetaminophen | 54738-548 | Tablet | Over the counter monograph drugs | May 1, 2015 |
| Diphenhydramine Hydrochloride | 54738-116 | Capsule | Over the counter monograph drugs | May 1, 2015 |
| Diphenhydramine Hydrochloride | 54738-115 | Capsule | Over the counter monograph drugs | May 1, 2015 |
| Aspirin | 54738-111 | Tablet | Over the counter monograph drugs | May 1, 2015 |
| Anti Allergy | 54738-103 | Tablet | Over the counter monograph drugs | May 1, 2015 |
| Antacid | 54738-030 | Tablet, chewable | Over the counter monograph drugs | May 1, 2015 |
| Meclizine HCL | 54738-025 | Tablet, chewable | Over the counter monograph drugs | May 1, 2015 |
| Sodium bicarbonate | 54738-020 | Tablet | Over the counter monograph drugs | May 1, 2015 |
| Aspirin | 54738-559 | Tablet | Over the counter monograph drugs | April 1, 2015 |
| Apap | 54738-540 | Tablet | Over the counter monograph drugs | April 1, 2015 |
| Aspirin | 54738-128 | Tablet, chewable | Over the counter monograph drugs | April 1, 2015 |
| Chewable Acetaminophen Childrens | 54738-092 | Tablet, chewable | Over the counter monograph drugs | April 1, 2015 |
| Apap | 54738-040 | Tablet | Over the counter monograph drugs | April 1, 2015 |
| Simethicone | 54738-518 | Tablet, chewable | Over the counter monograph drugs | March 1, 2011 |
| Ferrous Sulfate | 54738-963 | Tablet | Other unapproved drugs | November 5, 2008 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.